Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21: 2071 8. S7.1.1-4. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748 54. S7.1.1-5. Raitt MH, Renfroe EG, Epstein AE, et al. Stable ventricular tachycardia is not a benign rhythm: insights from the antiarrhyth- mics versus implantable defibrillators (AVID) registry. Circulation. 2001;103:244 52. S7.1.1-6. Owens DK, Sanders GD, Heidenreich PA, et al. Effect of risk stratifi- cation on cost-effectiveness of the implantable cardioverter defibril- lator. Am Heart J. 2002;144:440 8. S7.1.1-7. Bass EB, Elson JJ, Fogoros RN, et al. Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown ori- gin. Am J Cardiol. 1988;62:1186 91. S7.1.1-8. Wyse DG, Friedman PL, Brodsky MA, et al. Life-threatening ven- tricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. J Am Coll Cardiol. 2001;38:1718 24. S7.1.1-9. Maury P, Baratto F, Zeppenfeld K, et al. Radio-frequency ablation as primary management of well-tolerated sustained monomor- phic ventricular tachycardia in patients with structural heart dis- ease and left ventricular ejection fraction over 30%. Eur Heart J. 2014;35:1479 85. S7.1.1-10. Pauriah M, Cismaru G, Magnin-Poull I, et al. A stepwise approach to the management of postinfarct ventricular tachycardia using catheter ablation as the first-line treatment: a single-center expe- rience. Circ Arrhythm Electrophysiol. 2013;6:351 6. S7.1.1-11. Larsen G, Hallstrom A, McAnulty J, et al. Cost-effectiveness of the implantable cardioverter-defibrillator versus antiar- rhythmic drugs in survivors of serious ventricular tachyar- rhythmias: results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy. Circulation. 2002;105:2049 57. S7.1.1-12. O Brien BJ, Connolly SJ, Goeree R, et al. Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS). Circulation. 2001;103:1416 21. S7.1.1-13. 